Assignee
UNION THERAPEUTICS AS
DK21 patents
Top patents by PatentIndex Score
US10463680B2Nov 5, 2019
Halogenated salicylanilides for treating clostridium infections
UNION THERAPEUTICS AS19 citations92
US10758553B2Sep 1, 2020
Antibacterial use of halogenated salicylanilides
UNION THERAPEUTICS AS10 citations89
US11045434B1Jun 29, 2021
Niclosamide formulations for treating disease
UNION THERAPEUTICS AS24 citations88
US10857164B2Dec 8, 2020
Halogenated salicylanilides for treating Clostridium infections
UNION THERAPEUTICS AS10 citations78
US11299497B2Apr 12, 2022
Substituted tetrahydropyran dihydrothienopyrimidines and their use as phosphodiesterase inhibitors
UNION THERAPEUTICS AS2 citations72
US11529361B2Dec 20, 2022
Halogenated salicylanilides for treating Clostridium infections
UNION THERAPEUTICS AS1 citations71
US11384096B2Jul 12, 2022
Substituted azetidine dihydrothienopyridines and their use as phosphodiesterase inhibitors
UNION THERAPEUTICS AS4 citations71
US11365204B2Jun 21, 2022
Substituted dihydrothienopyrimidines and their use as phosphodiesterase inhibitors
UNION THERAPEUTICS AS5 citations71
US11292799B2Apr 5, 2022
Substituted azetidine dihydrothienopyrimidines and their use as phosphodiesterase inhibitors
UNION THERAPEUTICS AS5 citations71
US11285164B2Mar 29, 2022
Antibacterial use of halogenated salicylanilides
UNION THERAPEUTICS AS2 citations70
US11324708B1May 10, 2022
Niclosamide formulations for treating disease
UNION THERAPEUTICS AS3 citations67
US11220514B2Jan 11, 2022
Methods for the preparation of 1,3-benzodioxole heterocyclic compounds
UNION THERAPEUTICS AS4 citations63
US11370799B2Jun 28, 2022
Methods for the preparation of 1,3-benzodioxole heterocyclic compounds
UNION THERAPEUTICS AS4 citations62
US11981681B2May 14, 2024
Substituted azetidine dihydrothienopyridines and their use as phosphodiesterase inhibitors
UNION THERAPEUTICS AS1 citations60
US11866445B2Jan 9, 2024
Substituted dihydrothienopyrimidines and their use as phosphodiesterase inhibitors
UNION THERAPEUTICS AS1 citations60
US11331327B2May 17, 2022
Antibacterial use of halogenated salicylanilides
UNION THERAPEUTICS AS0 citations59
US11324761B2May 10, 2022
Antibacterial use of halogenated salicylanilides
UNION THERAPEUTICS AS0 citations59
US11213533B2Jan 4, 2022
Combinations comprising dibromopropamidine or diminazene and a tetracycline anti-bacterial agent
UNION THERAPEUTICS AS0 citations58
US12084457B2Sep 10, 2024
Methods for the preparation of 1,3-benzodioxole heterocyclic compounds
UNION THERAPEUTICS AS0 citations53
US12036312B2Jul 16, 2024
Non-aqueous topical compositions comprising a halogenated salicylanilide
UNION THERAPEUTICS AS0 citations51
US12409172B2Sep 9, 2025
Dosage regimen
UNION THERAPEUTICS AS0 citations39